Zenicor (ZENI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
6 Jun, 2025Executive summary
Revenue for 2024 increased by 4% year-over-year to 25,306 KSEK, marking the company's best year to date.
Operating income turned positive at 217 KSEK for the full year, compared to -3,974 KSEK in 2023.
Fourth quarter revenue rose 5% year-over-year to 6,882 KSEK, with operating income at 1,181 KSEK.
Transitioned from a single-product company to a full-service provider with Zenicor Solution, securing key contracts in Sweden.
Screening projects in Sweden and the UK are progressing, with results expected in 2025.
Financial highlights
Full-year revenue: 25,306 KSEK (24,351 KSEK in 2023); Q4 revenue: 6,882 KSEK (6,567 KSEK in Q4 2023).
Full-year operating income: 217 KSEK (-3,974 KSEK in 2023); Q4 operating income: 1,181 KSEK (-836 KSEK in Q4 2023).
Operating income per share for 2024: 0.02 SEK (-0.44 SEK in 2023); Q4: 0.13 SEK (-0.09 SEK in Q4 2023).
Net cash flow for the year was negative, with cash and cash equivalents at 911 KSEK at year-end.
Net debt reduced by 0.8 MSEK in Q4 due to new loans and repayments.
Outlook and guidance
Continued growth and increased sales of Zenicor Solution expected in Sweden, Finland, and the UK in 2025.
Focus on winning new contracts and tenders to ensure revenue growth and international competitiveness.
Screening project results and AI/ML algorithm evaluations anticipated to strengthen market position.
Latest events from Zenicor
- Strong revenue growth and profitability in 2025, with robust outlook for 2026.ZENI
Q4 202513 Feb 2026 - Rights issue and new contracts support rapid growth in arrhythmia diagnostics and early care.ZENI
Investor Update4 Nov 2025 - Q3 2025 revenue up 10% year-over-year, with positive profit and new growth financing secured.ZENI
Q3 202527 Oct 2025 - Q2 2025 saw 10% revenue growth, positive profit, and key wins in Finland and the UK.ZENI
Q2 202531 Jul 2025 - Revenue growth and positive operating income mark a strong Q3, despite liquidity challenges.ZENI
Q3 202413 Jun 2025 - Q2 2024 saw record Q2 revenue, positive operating profit, and strengthened liquidity.ZENI
Q2 202413 Jun 2025 - Record Q1 revenue and UK contracts drive Zenicor's return to profitability.ZENI
Q1 20256 Jun 2025